GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | +10.0% | 250 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | +25.0% | 275 | +44.0% | 0.00% | +50.0% |
| Q2 2019 | $8,000 | 0.0% | 191 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,000 | +14.3% | 191 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | -12.5% | 191 | +1.6% | 0.00% | -33.3% |
| Q3 2018 | $8,000 | -63.6% | 188 | -66.0% | 0.00% | -57.1% |
| Q2 2018 | $22,000 | 0.0% | 553 | -3.7% | 0.01% | +40.0% |
| Q1 2018 | $22,000 | -81.0% | 574 | -80.9% | 0.01% | -83.9% |
| Q4 2016 | $116,000 | -10.1% | 3,000 | 0.0% | 0.03% | -18.4% |
| Q3 2016 | $129,000 | -0.8% | 3,000 | 0.0% | 0.04% | -13.6% |
| Q2 2016 | $130,000 | +6400.0% | 3,000 | +6283.0% | 0.04% | +4300.0% |
| Q4 2015 | $2,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |